There is evidence of an innervation of the mucosal immune system by peptidergic fibers. The modulation of the mitogenic response of the murine Peyer's patch lymphocytes by several peptides present in the gastrointestinal tract, namely, the carboxy-terminal octapeptide of cholecystokinin (CCK-8), the entire molecule cholecystokinin-pancreozymin (CCK-PZ), the calcitonin gene-related peptide (CGRP) and the vasoactive intestinal peptide (VIP), was studied. The proliferative response of the T lymphocytes induced by 2.5 μg/ml concanavaline A (Con A) was dose dependently inhibited by CGRP and VIP, with a maximal inhibition of 40% and 55% with 10−7 M CGRP and VIP, respectively. On the contrary, CCK-PZ exerted a significant stimulatory effect, 48% increase in thymidine incorporation being observed with 62.5 mU/ml (Crick units) CCK-PZ. CCK-8 was found to have no effect on the T cell proliferation. None of the peptides tested were able to modify the mitogenic response of Peyer's patch B lymphocytes induced by 20 μg/ml lipopolysaccharide (LPS), except for CCK-PZ which induced a significant inhibition of the mitogenesis with a maximal effect of 45% inhibition at 500 mU/ml. These preliminary results show that CGRP, VIP and CCK-PZ can affect the murine Peyer's patch T and B lymphocyte response and suggest that they could be implicated in the modulation of the local immune response in the intestine.
BellingerD.L.LortonD.RomanoT.D.OlschowskaJ.A.FeltenS.Y.FeltenD.L., 1990. Neuropeptide innervation of lymphoid organs. Ann. N.Y. Acad. Sci.594:17.
2.
BlalockJ.E.1984. The immune system as a sensory organ. J. Immunol.182:1067.
3.
BoudardF.BastideM., 1991. Inhibition of mouse T-cell proliferation by CGRP and VIP: Effects of these neuropeptides on IL-2 production and cAMP synthesis. J. Neurosci. Res.29:29.
4.
BoudardF.BastideM., 1991. Modulation of the mitogenic response of murine T lymphocytes by CGRP-SP and VIP-SP combinations. Int. J. Immunotherapy7:153.
5.
BullochK.RadojcicT.YuR.LenhardL.BairdS., 1991. The distribution and function of calcitonin gene-related peptide in the mouse thymus and spleen. Prog. Neuroendocrin Immunol. 4:186.
6.
CallardR.E.1991. Human B cell responses to cytokines. In Cytokines. BalkwillF.R., ed. IRL Press, Oxford, New York, Tokyo, p. 121.
7.
CarrD.J.J.RadulescuR. T.De CostaB.R.RiceK.C.BlalockJ.E., 1990. Differential effect of opioids on immunoglobulin production by lymphocytes isolated from Peyer's patches and spleen. Life Sci. 47:1059.
8.
CasiniA.GeppetiP.MaggiC.A.SurrentiC., 1989. Effects of calcitonin gene-related peptide (CGRP), neurokinin A and neurokinin A (4–10) on the mitogenic response of human peripheral blood mononuclear cells. Archs Pharmacol. 339:354.
9.
CavagnaroJ.LewisR.M., 1989. Bidirectional regulatory circuit between the immune and neuroendocrine systems. Year Immmunol. 4:241.
10.
CrawleyJ.N.1985. Comparative distribution of cholecystokinin and other neuropeptides. Ann. N.Y. Acad. Sci.448:1.
11.
CrickJ.HarperA.A.RaperH.S., 1950. On the preparation of secretin and pancreozymin. J. Physiol.110:367.
12.
CroitoruK.SteadR.H.BienenstockJ.StaniszA.M., 1989. The role of neuropeptides in modulating the intestinal immune response. In Interactions among CNS, Neuroendocrine and Immune systems: HaddenJ. W.MasekK.NisticoG., eds Pythagora Press, Rome-Milan, p. 439.
13.
DanekA.O'DorisioM.S.O'DorisioT.M.GeorgeJ.M., 1983. Specific binding sites for vasoactive intestinal peptide on nonadherent peripheral blood lymphocytes. J. Immunol.131:1173.
14.
ElitsurY.LukG.D., 1991. The inhibition effect of cholecystokinin in human colonic lamina propria lymphocyte proliferation, and reversal by the cholecystokinin receptor antagonist L-364718. Neuropeptides20:41.
15.
FeltenD.L.FeltenS.Y.CarlsonS.L.OlschowkaJ.A.LivnatS., 1985. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol.135:755s.
16.
FerraraA.McMillenM.A.GoldenringJ. R.SchaferH.C.ModlinI.M., 1989. Cholecystokinin (CCK) effect on human lymphocyte activation. Gastroenterology96.AI48.
17.
FerraraA.McMillenM.A.ScheaferH.C.ZuckerK.A.ModlinI.M., 1990. Effect of cholecystokinin receptor blockade on human lymphocyte proliferation. J. Surg. Res.48:354.
18.
FreierS.LebenthalE.FreierM.ShahP.C.ParkB.H.LeeP.C., 1983. IgE and IgD antibodies to cow milk and soy protein in duodenal fluid: Effects of pancreozymin and secretin. Immunology49:69.
19.
FriedM.SchwizerW.BeglingerC.KellerU.JansenJ.B.LancerC.B., 1991. Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide. Diabetologia74:721.
20.
IvyA.C.OldbergE., 1928. A hormone mechanism for gall-bladder contraction and evacuation. Am. J. Physiol.86:599.
21.
JorpesJ.E.1968. The isolation and chemistry of secretin and cholecystokinin. Gastroenterology55:157.
22.
KaufmannR.LindschauC.BuchnerK.OttT., 1992. CCKB receptor stimulation mediates (Ca2+)i increase but no PKC activation in Jurkat T-cells. Neuroreport3:697.
23.
KonturekS.J.BilskiJ.HladijM.KrzyzekE.CaiR.Z.SchallyA.V., 1991. Role of cholecystokinin, gastrin and gastrin-releasing peptide int he regulation of pancreatic secretions in cats. Digestion49:97.
24.
KurkowskiR.RummerW.HeynC., 1990. Substance P immunoreactive nerve fibers in tracheo bronchial lymph nodes of the guinea pig: Origin, ultrastructure and coexistence with other peptides. Peptides11:13.
25.
LignonM.F.BernadN.MartinezJ., 1991. Pharmacological characterization of type B cholecystokinin sites on the human Jurkat T lymphocyte cell line. Mol. Pharmacol.39:615.
26.
LignonM.F.BernadN.MartinezJ., 1993. Cholecystokinin increases intracellular Ca2+ concentration in the human Jurkat T lymphocyte cell line. Eur. J. Pharmacol.245:241.
27.
McGillisJ.P.HumphreysS.ReidS., 1991. Characterization of functional calcitonin gene-related peptide receptors on the rat lymphocytes. J. Immunol.147:3482.
28.
McGillisJ.P.HumphreysS.RangnekarV.CiacellaJ., 1993. Modulation of B lymphocyte differentiation by calcitonin gene-related peptide (CGRP). II. Inhibition of LPS-induced K light chain expression by CGRP. Cell. Immunol.150:405.
29.
McMillenM.A.FerraraA.SchaeferH.C.GoldenringJ.R.ZuckerK.A.ModlinI.M., 1990. Cholecystokinin mediates a calcium signal in human peripheral blood mononuclear cells and is a co-mitogen. Ann. N.Y. Acad. Sci.594:399.
30.
OttawayC.A.GreenbergG.R., 1984. Interaction of vasoactive intesinal peptide with mouse lymphocytes: Specific binding and the modulation of mitogen responses. J. Immunol.132:417.
31.
OttawayC.A.1987. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells. Immunology62:291.
32.
SacerdoteP.RuffM.PertC.B., 1988. Cholecystokinin and the immune system: Receptor-mediated chemotaxis of human and rat monocytes. Peptides9:29.
33.
SacerdoteP.WiedermanC.WahlL.M.PertC.B.RuffM.R., 1991. Vizualisation of cholecystokinin receptors on a subset of human monocytes and in rat spleen. Peptides12:167.
34.
SeguraJ.J.GuerreroJ.M.GobernaR.CalvoJ.R., 1991. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages. Regul. Pept.33:133.
35.
SoderO.HellströmP.M., 1987. Neuropeptide regulation of human thymocyte, guinea pig T lymphocyte and rat B lymphocyte mitogenesis. Int. Archs Allergy Appl. Immunol.84:205.
36.
StaniszA.M.BefusD.BienenstockJ., 1986. Differential effects of Vasoactive intestinal peptide, Substance P, and Somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J. Immunol.136:152.
37.
StaniszA.M.ScicchitanoR.DazinP.BienenstockJ.PayanD.G., 1987. Distribution of Substance P receptors on murine spleen and Peyer's patch T and B cells. J. Immunol.139:749.
38.
SteadR.H.BienenstockJ.StaniszA., 1987. Neuropeptide regulation of mucosal immunity. Immunol. Rev.100:333.
39.
TakedaK.KoshimotoH.UchiumiF.HaunR.S.DixonJ.E.KatoT., 1989. Postnatal development of cholecystokinin-like immuno-reactivity and its mRNA level in rat brain regions. J. Neurochem.53:772.
40.
TangS.C.BrausteinerH.WiedermannC.J., 1992. Regulation of human T lymphoblast growth by sensory neuropeptides: Augmentation of cholecystokinin-induced inhibition of Molt-4 proliferation by somatostatin and vasoactive intestinal peptide in vitro. Immunol. Lett.34:237.
41.
UmedaY.TakamiyaM.YoshizakiH.ArisawaM., 1988. Inhibition of mitogen-stimulated T lymphocytes proliferation by calcitonin gene-related peptide. Biochem. Biophys. Res. Commun.154:227.
42.
UmedaY.ArisawaM., 1989. Inhibition of natural killer activity by calcitonin gene-related peptide. Immunopharmacol. Immunotoxicol.11:309.
43.
UmedaY.ArisawaM., 1989. Characterization of the calcitonin Gene-related peptide receptor in mouse T lymphocytes. Neuropeptides14:237.
44.
Van TolE.A.VerspagetH.W.LamersC.B., 1993. Effects of CCK-8 and CCK-33 on human natural killer cell activity: Studies on intestinal lamina propria and peripheral blood mononuclear cells. Immunopharmacol. 25:11.
45.
VigneryA.WangF.GanzM.B., 1991. Macrophages express functional receptors for cacitonin gene-related peptide. J. Cell. Physiol.149:301.
46.
WangF.MilletI.BottomlyK.VigneryA., 1992. Calcitonin gene-related peptide inhibits Interleukin-2 production by murine T lymphocytes. J. Biol. Chem.267:21052.
47.
WeiheE.NohrD.MichelS.MüllerS.ZentelH.J.FinkT.KrekelJ., 1991. Molecular anatomy of the neuro-immune connection. Int. J. Neurosci.59:1.
48.
YeS.ApplegrenR.R.DavisJ. M.CheungH.T., 1989. Modulation of lymphocyte motility by β-endorphin and met-enkephalin. Immunopharmacol. 17:81.
